drugset / Trial / NCT00742963
Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether TH-302 in combination with Doxorubicin is safe and effective in the treatment of Advanced Soft Tissue Sarcoma.
Timeline
- Start
- 2008-08
- Primary completion
- 2013-07
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Evofosfamide | Other / unclassified | 180 mg/m2 | Intravenous |
| Subject | Evofosfamide | Other / unclassified | 240 mg/m2 | Intravenous |